Biotin-decorated anti-cancer nucleotide theranostic conjugate of human serum albumin

Biotin-decorated anti-cancer nucleotide theranostic conjugate of human serum albumin: Where the seed meets the soil?

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	260-264
Number of pages	5
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	28
Issue number	3
DOIs	https://doi.org/10.1016/j.bmcl.2017.12.061
Publication status	Published - 1 Feb 2018

Anti-tumor activity, Biotinylated albumin conjugate, Dual-labeled human serum albumin, Fluorescence-based molecular imaging, Trifluorothymidine theranostic conjugate, CELLS, PERMEABILITY, DRUG-DELIVERY, VERSATILE PLATFORM, BREAST-CANCER, NANOPARTICLES, FC-RECEPTOR, THERAPY, DEPENDENT MULTIVITAMIN TRANSPORTER, EXPRESSION, Biotin/chemistry, Theranostic Nanomedicine, Humans, Structure-Activity Relationship, Dose-Response Relationship, Drug, Neoplasms, Experimental/drug therapy, Molecular Structure, Cell Proliferation/drug effects, Mice, SCID, Antineoplastic Agents/chemical synthesis, Animals, Cell Line, Tumor, Mice, Serum Albumin, Human/chemistry, Nucleotides/chemical synthesis, Drug Screening Assays, Antitumor

ID: 12080297